News & Updates
Filter by Specialty:
COVID-19 jabs help reduce long-term symptoms
COVID-19 vaccination appears to reduce the odds of long COVID symptoms, with continuous improvement following a second dose, at least in the first few months after the shot, suggests a study.
COVID-19 jabs help reduce long-term symptoms
27 May 2022
Long COVID: What factors contribute to the risk?
Only a minority of patients are considered fully recovered 1 year after being discharged from hospital due to COVID-19, with women and obese individuals at increased risk of long COVID, according to results of the prospective PHOSP-COVID* study presented at ECCMID 2022 and published in The Lancet.
Long COVID: What factors contribute to the risk?
25 May 2022
What is the most preferred first-line agent for paediatric alopecia areata?
In the treatment of paediatric alopecia areata (AA), an autoimmune, nonscarring hair loss disorder with a variable disease course and significant psychosocial impact, the most preferred first-line agent is topical corticosteroids, followed by contact immunotherapy, according to a study.
